Al-Abbas Omar, Alshaikhli Alfarooq, Amran Hashed A
Family Medicine Residency Program, Medical Education, Hamad Medical Corporation, Doha, QAT.
Internal Medicine, Beaumont Health, Michigan, USA.
Cureus. 2021 Jan 26;13(1):e12917. doi: 10.7759/cureus.12917.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was declared a pandemic by the World Health Organization in March 2020. Initially, infected patients presented with fever, nonproductive cough, dyspnea, myalgia, shortness of breath, and radiographic evidence of pneumonia. However, others presented with atypical cardiac manifestation. As this disease is new, the full picture of the disease presentation is not fully understood. Since December 2019, many morbidities related to coronavirus disease-2019 (COVID-19) were documented, including vascular complications like venous thromboembolism (VTE), pulmonary embolism (PE), and deep vein thrombosis (DVT) in acutely ill COVID-19 patients. Hereby, we are writing a case of a patient with COVID-19 infection suffering from new-onset atrial fibrillation (AF). It was complicated by multiple arterial embolisms involving different organs despite the use of an intermediate dose of low-molecular-weight heparin (LMWH), and the patient was eventually discharged home on a direct-acting oral anticoagulant (DOAC).
2020年3月，世界卫生组织宣布严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染为大流行病。最初，感染患者表现为发热、干咳、呼吸困难、肌痛、呼吸急促以及肺炎的影像学证据。然而，其他患者则表现出非典型的心脏症状。由于这种疾病是新出现的，其完整的临床表现尚未完全了解。自2019年12月以来，已记录了许多与2019冠状病毒病（COVID-19）相关的病症，包括急性病COVID-19患者的血管并发症，如静脉血栓栓塞（VTE）、肺栓塞（PE）和深静脉血栓形成（DVT）。在此，我们撰写了一例患有COVID-19感染并新发房颤（AF）的患者病例。尽管使用了中等剂量的低分子肝素（LMWH），但该病例仍并发了累及不同器官的多处动脉栓塞，患者最终在使用直接口服抗凝剂（DOAC）后出院回家。
